InnoCan Pharma Corp. focuses on the development and sale of CBD-integrated pharmaceuticals including topical treatments for relief of psoriasis symptoms as well as the treatment of muscle pain and rheumatic pain. It operates through the following segments: Research, Development, Marketing, Distribution and Sales Of Innocanbranded OTC Pharmaceutical Products; Research and Development Of Non-Pharmaceutical Products for Third Parties in Exchange for Fees or Royalties; and (Iii) Research and Development of Hydrogels Containing Liposomes Intended for Licensing or Sale to Third Party Pharmaceutical Corporations for Manufacturing, Distribution and Sales. The company was founded in October2017 and is headquartered in Herzliya, Israel.